- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04877158
Pilot Intervention for Social Biases in Eating Disorders (SBPI)
Pilot Intervention for Attribution Biases in Eating Disorders
Study Overview
Status
Intervention / Treatment
Detailed Description
This project will recruit subjects with eating disorders in the Dallas Fort Worth area. Pre-assessment measures of anxiety, self-esteem, depression, eating disorder symptoms, and attributional style will be completed before the intervention. Participants attend four weekly sessions of a group psychoeducational intervention. The intervention includes an art therapy experiential activity, psychoeducation on social function, reflection and discussion of sample videos and scripts, homework assignments, and guided discussions. Post-assessments will be completed 1-4 weeks and 3-5 months after the interventions is completed.
A. Intake and Screen: Screening checklist for ED symptoms. Demographic Sheet; Clinical History (low BMI); Mini-International Neuropsychiatric Interview for DSM-V (MINI); Eating Disorder Assessment for DSM-V (EDA-5); Wechsler Abbreviated Scale of Intelligence (WASI)
B. Pre/Post Measures (Done at three time points, Pre:1-4 weeks before intervention; Post1: 1-4 weeks after intervention; and Post2: 3-5 months after intervention).
- Internal, Personal, and Situational Attribution Questionnaire, (IPSAQ)
- State Self-Esteem Scale (SSE)
- Trait Self-Esteem Scale (TSE)
- Eating Disorder Examination Questionnaire, (EDE-Q)
- The Quick Inventory of Depression, Clinician-Rated (QIDS)
- Structured Interview Guide for Hamilton Anxiety Scale (SIGH-A)
C. Feedback about the intervention is obtained from queries immediately after the last session and at the follow-up visits.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75390-8828
- UTSW
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- eating disorder, current or recent
- female
- appropriate for partial hospital, intensive outpatient or outpatient treatment
Exclusion Criteria:
- medically unstable
- in inpatient or residential treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Self-Blame and Perspective-Taking Intervention
These participants are enrolled with intent to participate in the group therapy intervention.
|
The intervention is a group therapy that consists of experiential art tasks followed by psychoeducation about social behaviors with weekly homework.
There are four sessions, each one week apart.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in self- attribution (externalizing bias score) from Pre-assessment to Post-assessment 1
Time Frame: Baseline, 4 weeks after intervention
|
Internal Personal Situational Attributions Questionnaire (IPSAQ) measures externalizing bias (EB) that is calculated by subtracting the number of internal attributions for negative events from the number of internal attributions for positive events.
A positive EB score indicates strong self-serving bias (blaming oneself less for negative events than for positive events).
|
Baseline, 4 weeks after intervention
|
|
Change in state self-esteem score from Pre-assessment to Post-assessment 1
Time Frame: Baseline, 4 weeks after intervention
|
State Self-Esteem Scale measures a participant's self-esteem at a given point in time.
Possible scores range from 0-5 with higher scores indicating better outcome.
|
Baseline, 4 weeks after intervention
|
|
Change in trait self-esteem score from Pre-assessment to Post-assessment 1
Time Frame: Baseline, 4 weeks after intervention
|
Rosenberg trait self-esteem scale measures trait self-esteem (TSE).
Possible scores range from 0-4 (from 1: strongly disagree, to 4: strongly agree), with higher scores indicating higher TSE.
|
Baseline, 4 weeks after intervention
|
|
Study components feedback score
Time Frame: 4 weeks after starting intervention
|
The Attribution Bias Intervention Questionnaire addressed study component feedback using both a rating scales and free form written commentary.
Possible scores range from 1 to 10 with higher scores indicating more positive values.
|
4 weeks after starting intervention
|
|
Patient satisfaction score
Time Frame: 5-9 weeks after intervention
|
The Attribution Bias Feedback Form measured patient satisfaction (the impact and value of study) with free-form verbal responses as well as a single rating scale.
Possible scores range from 1 to 5 with higher scores indicating more satisfaction with the intervention.
|
5-9 weeks after intervention
|
|
Change in eating disorder symptoms score from Pre- assessment to Post-assessment 1
Time Frame: Baseline, 4 weeks after intervention
|
The Eating Disorder Examination Questionnaire measures the severity of eating disorder symptoms.
Possible scores on global eating disorder pathology range from 0 to 6 with higher scores indicating more severity of eating disorder, with scores of 2 or less typical of normative eating behavior/cognitions and scores of 2 to 6 are consistent with eating disorder symptoms, with higher scores suggesting more types of disordered eating are present.
|
Baseline, 4 weeks after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in depression symptoms scores from Pre-assessment to Post-assessment 1
Time Frame: Baseline, 4 weeks after intervention
|
QIDS (Quick Inventory of Depressive Symptoms) measures depression symptoms.
Possible scores range from 0-27, with scores of 5 or lower indicative of no depression, scores from 6 to 10 indicating mild depression, 11 to 15 indicating moderate depression, 16 to 20 reflecting severe depression, and total scores greater than 21 indicating very severe depression.
|
Baseline, 4 weeks after intervention
|
|
Change in depression symptoms scores from Pre-assessment to Post-assessment 2
Time Frame: Baseline, 3-5 months after intervention
|
QIDS (Quick Inventory of Depressive Symptoms) measures depression symptoms.
Possible scores range from 0-27, with scores of 5 or lower indicative of no depression, scores from 6 to 10 indicating mild depression, 11 to 15 indicating moderate depression, 16 to 20 reflecting severe depression, and total scores greater than 21 indicating very severe depression.
|
Baseline, 3-5 months after intervention
|
|
Change in anxiety symptoms score from Pre-assessment to Post-assessment 1
Time Frame: Baseline, 4 weeks after intervention
|
SIGH-A (Structured Clinical Interview for Hamilton Anxiety Scale) measures Anxiety symptoms.
Possible scores range from 0-56 with score of 0 means no anxiety symptom.
( <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe.
Lower scores indicate better outcome)
|
Baseline, 4 weeks after intervention
|
|
Change in anxiety symptoms score from Pre-assessment to Post-assessment 2
Time Frame: Baseline, 3-5 months after intervention
|
SIGH-A (Structured Clinical Interview for Hamilton Anxiety Scale) measures anxiety symptoms.
Possible scores range from 0-56 with score of 0 means no anxiety symptom ; <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe.
Lower scores indicate better outcome.
|
Baseline, 3-5 months after intervention
|
|
Change in eating disorder symptoms score from Pre-assessment to Post-assessment 2
Time Frame: Baseline, 3-5 months after intervention
|
The Eating Disorder Examination Questionnaire measures the severity of eating disorder symptoms.
Possible scores on global eating disorder pathology range from 0 to 6 with higher scores indicating more severity of eating disorder, with scores of 2 or less typical of normative eating behavior/cognitions and scores of 2 to 6 are consistent with eating disorder symptoms, with higher scores suggesting more types of disordered eating are present.
|
Baseline, 3-5 months after intervention
|
|
Change in self- attribution (externalizing bias score) from Pre-assessment to Post-assessment 2
Time Frame: Baseline, 3-5 months after intervention
|
Internal Personal Situational Attributions Questionnaire (IPSAQ) measures externalizing bias (EB) that is calculated by subtracting the number of internal attributions for negative events from the number of internal attributions for positive events.
A positive EB score therefore indicates strong self-serving bias (blaming oneself less for negative events than for positive events).
|
Baseline, 3-5 months after intervention
|
|
Change in state self-esteem score from Pre-assessment to Post-assessment 2
Time Frame: Baseline, 3-5 months after intervention
|
State self-esteem scale measures a participant's self-esteem at a given point in time.
Possible scores range from 0-5 with higher scores indicating better outcome.
|
Baseline, 3-5 months after intervention
|
|
Change in trait self-esteem score from Pre-assessment to Post-assessment 2
Time Frame: Baseline, 3-5 months after intervention
|
Rosenberg trait self-esteem scale measures Trait Self-Esteem (TSE).
Possible scores range from 0-4 (from 1: strongly disagree, to 4: strongly agree), with higher scores indicating higher TSE.
|
Baseline, 3-5 months after intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Carrie McAdams, MD PhD, University of Texas Southwestern Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU-042016-079
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anorexia Nervosa
-
Baylor College of MedicineEnrolling by invitationAnorexia Nervosa | Atypical Anorexia NervosaUnited States
-
Rosemary Claire RodenChildren's Miracle NetworkTerminatedBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
University of California, San DiegoActive, not recruitingAnorexia Nervosa | Bulimia Nervosa | Atypical Anorexia Nervosa | Atypical Bulimia NervosaUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Bulimia Nervosa | Anorexia Nervosa in RemissionUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Fundació La Marató de TV3RecruitingAnorexia Nervosa | Anorexia Nervosa in Remission | Anorexia Nervosa Restricting TypeSpain
-
Duke UniversityCompletedAdolescent Anorexia Nervosa | Subthreshold Anorexia NervosaUnited States
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Istituto Auxologico ItalianoCatholic University of the Sacred Heart; University of Turin, Italy; Open University and other collaboratorsRecruitingAnorexia Nervosa/BulimiaItaly
-
Maimónides Biomedical Research Institute of CórdobaHospital Universitario Reina Sofia de CordobaNot yet recruitingAnorexia Nervosa Restricting Type | Anorexia Nervosa (DSM-IV Revised Criteria)Spain
-
University Hospital, MontpellierCompleted
Clinical Trials on Self-Blame and Perspective-Taking Intervention
-
University of ManitobaCompleted
-
Maastricht University Medical CenterCompleted
-
Connecticut Children's Medical CenterChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsNot yet recruitingSickle Cell Disease | Sickle Cell Disease (SCD) | Sickle Cell Anemia in Children | Sickle Cell | Sickle Cell Anemia (HbSS)United States
-
The Hospital for Sick ChildrenCompleted
-
University College, LondonUnknownInflammatory Bowel Disease (IBD)
-
University of Wisconsin, MadisonCompleted
-
Université Libre de BruxellesJules Bordet Institute; Centre de Psycho-Oncologie (CPO); Hôpital Universitaire...RecruitingMyeloma Multiple | Metastatic CancersBelgium
-
University of ConnecticutNational Institute of Nursing Research (NINR)CompletedBreastfeeding | Breast PainUnited States
-
University Medical Center GroningenCompletedFunctional Motor DisorderNetherlands
-
Yale UniversityNational Institute of Nursing Research (NINR); Beijing Ditan Hospital; Shanghai...Completed